334 related articles for article (PubMed ID: 34190174)
21. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.
Li B; Liu A; Wen Y; Yang G; Zhao J; Li X; Mao Y; Li B
J Clin Lab Anal; 2021 Sep; 35(9):e23932. PubMed ID: 34403527
[TBL] [Abstract][Full Text] [Related]
22. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
[TBL] [Abstract][Full Text] [Related]
23. The effect of hepatocellular carcinoma bile duct tumor thrombi in liver transplantation.
Kim JM; Kwon CH; Joh JW; Park JB; Gwak MS; Lee JH; Kim GS; Kim SJ; Lee SK
Hepatogastroenterology; 2014 Sep; 61(134):1673-6. PubMed ID: 25436361
[TBL] [Abstract][Full Text] [Related]
24. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
25. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Lai Q; Inostroza M; Rico Juri JM; Goffette P; Lerut J
HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980
[TBL] [Abstract][Full Text] [Related]
26. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
[TBL] [Abstract][Full Text] [Related]
27. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Han K; Tzimas GN; Barkun JS; Metrakos P; Tchervenkov JL; Hilzenrat N; Wong P; Deschênes M
Can J Gastroenterol; 2007 Jan; 21(1):39-45. PubMed ID: 17225881
[TBL] [Abstract][Full Text] [Related]
28. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
Meischl T; Rasoul-Rockenschaub S; Győri G; Scheiner B; Trauner M; Soliman T; Berlakovich G; Pinter M
United European Gastroenterol J; 2021 Mar; 9(2):209-219. PubMed ID: 32741316
[TBL] [Abstract][Full Text] [Related]
29. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
30. Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Chiang JH; Lee PC; Lee SD
BMC Gastroenterol; 2010 Dec; 10():146. PubMed ID: 21194431
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional tumor volume and serum alpha-fetoprotein are predictors of hepatocellular carcinoma recurrence after liver transplantation: refined selection criteria.
Kashkoush S; El Moghazy W; Kawahara T; Gala-Lopez B; Toso C; Kneteman NM
Clin Transplant; 2014 Jun; 28(6):728-36. PubMed ID: 24708263
[TBL] [Abstract][Full Text] [Related]
32. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
34. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
35. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
36. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
[TBL] [Abstract][Full Text] [Related]
37. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.
Wongjarupong N; Negron-Ocasio GM; Chaiteerakij R; Addissie BD; Mohamed EA; Mara KC; Harmsen WS; Theobald JP; Peters BE; Balsanek JG; Ward MM; Giama NH; Venkatesh SK; Harnois DM; Charlton MR; Yamada H; Algeciras-Schimnich A; Snyder MR; Therneau TM; Roberts LR
World J Gastroenterol; 2018 Mar; 24(12):1321-1331. PubMed ID: 29599607
[TBL] [Abstract][Full Text] [Related]
38. Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Jiang L; Liao A; Yan L; Li B; Zhu W; Wen T
Hepatogastroenterology; 2014 May; 61(131):747-51. PubMed ID: 26176068
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence.
Montalvá EM; Cantos M; Boscà A; Rubín A; Vinaixa C; Granero P; Maupoey J; López-Andújar R
Transplant Proc; 2016 Nov; 48(9):2966-2968. PubMed ID: 27932120
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
